Beaird Harris Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$398K Hold
1,098
0.02% 107
2026
Q1
$386K Buy
1,098
+19
+2% +$6.77K 0.03% 107
2025
Q4
$353K Sell
1,079
-21
-2% -$6.66K 0.02% 108
2025
Q3
$310K Sell
1,100
-4
-0.4% -$1.16K 0.02% 112
2025
Q2
$308K Buy
1,104
+15
+1% +$4.25K 0.02% 113
2025
Q1
$339K Hold
1,089
0.03% 100
2024
Q4
$284K Buy
1,089
+199
+22% +$59K 0.02% 112
2024
Q3
$287K Hold
890
0.03% 118
2024
Q2
$278K Hold
890
0.03% 107
2024
Q1
$253K Hold
890
0.02% 104
2023
Q4
$256K Buy
890
+7
+0.8% +$1.91K 0.03% 99
2023
Q3
$237K Hold
883
0.03% 91
2023
Q2
$196K Hold
883
0.02% 100
2023
Q1
$213K Hold
883
0.04% 83
2022
Q4
$232K Hold
883
0.04% 81
2022
Q3
$199K Hold
883
0.04% 81
2022
Q2
$215K Hold
883
0.06% 66
2022
Q1
$214K Hold
883
0.08% 81
2021
Q4
$199K Buy
+883
New +$186K 0.07% 117

Other funds holding AMGN

Beaird Harris Wealth Management's AMGN Position: Q2 2026 in Review

Beaird Harris Wealth Management held its Amgen (AMGN) position steady in Q2 2026 at 1,098 shares worth $398K. The position accounts for 0.02% of the portfolio, ranked #107.

Beaird Harris Wealth Management first reported a position in AMGN in Q4 2021 and has held it in 19 quarters since. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Beaird Harris Wealth Management held 1,098 shares of Amgen worth $398K as of Q2 2026.
  • Beaird Harris Wealth Management left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.02% of Beaird Harris Wealth Management's portfolio in Q2 2026, its #107 holding.
  • Beaird Harris Wealth Management first reported a position in Amgen in Q4 2021 and has held it in 19 quarters since.
  • 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Beaird Harris Wealth Management's 13F filing for Q2 2026, filed 8 Jul 2026.